Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2017
Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in UrineHatim Husain, Vladislava O Melnikova, Karena Kosco, et al.BMJ Open|January 26, 2021
Doctors of chiropractic working with or within integrated healthcare delivery systems: a scoping review protocolEric J Roseen, Bolanle Aishat Kasali, Kelsey Corcoran, et al.Cancer Medicine|December 13, 2021
Analysis of CDK12 alterations in a pan-cancer databaseElizabeth Pan, Angelo Cabal, Juan Javier-DesLoges, et al.JAMA Network Open|November 4, 2024
Actionable Structural Variant Detection via RNA-NGS and DNA-NGS in Patients With Advanced Non-Small Cell Lung CancerDwight Owen, Rotem Ben-Shachar, Josephine Feliciano, et al.Journal for Immunotherapy of Cancer|February 5, 2024
Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cellsGregory P Botta, Joseph Chao, Hong Ma, et al.Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 25, 2023
Expert Consensus Statement: Management of Dysphagia in Head and Neck Cancer PatientsMaggie A Kuhn, M Boyd Gillespie, Stacey L Ishman, et al.Journal of the American Dental Association (1939)|September 30, 2017
Evidence-based clinical practice guideline for the evaluation of potentially malignant disorders in the oral cavity: A report of the American Dental AssociationMark W Lingen, Elliot Abt, Nishant Agrawal, et al.Journal of the American Dental Association (1939)|October 30, 2017
Adjuncts for the evaluation of potentially malignant disorders in the oral cavity: Diagnostic test accuracy systematic review and meta-analysis-a report of the American Dental AssociationMark W Lingen, Malavika P Tampi, Olivia Urquhart, et al.Journal of Translational Medicine|October 22, 2024
Low PD-L1 expression, MAP2K2 alterations, and enriched HPV gene signatures characterize brain metastases in head and neck squamous cell carcinomaMichael J Dennis, Dean C Pavlick, Alec Kacew, et al.BMC Cancer|September 14, 2017
A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancerKerry Lynn Reynolds, Philippe L Bedard, Se-Hoon Lee, et al.Pageof 4